Cardiff Oncology, Inc. CRDF
CRDF
Cardiff Oncology, Inc. APLT
Applied Therapeutics, Inc. CRBP
Corbus Pharmaceuticals Holdings, Inc. ELTX
Elicio Therapeutics, Inc. MOLN
Molecular Partners AG FBRX
Forte Biosciences, Inc. PEPG
PepGen Inc. RANI
Rani Therapeutics Holdings, Inc. MIST
Milestone Pharmaceuticals Inc. SAVA
Cassava Sciences, Inc.
Cardiff Oncology, Inc. APLT
Applied Therapeutics, Inc. CRBP
Corbus Pharmaceuticals Holdings, Inc. ELTX
Elicio Therapeutics, Inc. MOLN
Molecular Partners AG FBRX
Forte Biosciences, Inc. PEPG
PepGen Inc. RANI
Rani Therapeutics Holdings, Inc. MIST
Milestone Pharmaceuticals Inc. SAVA
Cassava Sciences, Inc.
Performance
| Periode | CRDF | APLT | CRBP | ELTX | MOLN | FBRX | PEPG | RANI | MIST | SAVA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -37.82 % | -67.40 % | -0.92 % | 5.71 % | 8.85 % | 71.10 % | 270.47 % | 176.87 % | 27.91 % | 42.93 % |
| YTD | -43.66 % | -86.56 % | -28.07 % | 58.56 % | -14.17 % | -7.91 % | 46.42 % | -1.37 % | 1.38 % | 6.55 % |
| 1Y | -40.45 % | -89.50 % | -39.36 % | 65.99 % | -21.87 % | 22.73 % | 22.39 % | -9.43 % | 22.91 % | 10.15 % |
| 3Y | 81.82 % | -84.12 % | 134.69 % | 38.37 % | -36.67 % | -5.02 % | -61.15 % | -79.89 % | -39.73 % | -47.02 % |
| 5Y | -88.15 % | -99.48 % | -77.96 % | 38.37 % | -78.73 % | -97.54 % | -57.18 % | -86.91 % | -67.41 % | 159.29 % |
| 10Y | -99.43 % | -98.72 % | -81.84 % | 38.37 % | -78.73 % | -99.50 % | -57.18 % | -86.91 % | -85.69 % | 54.21 % |
| From the beginning | -99.85 % | -98.72 % | -90.38 % | 38.37 % | -78.73 % | -99.50 % | -57.18 % | -86.91 % | -85.69 % | -86.61 % |